All Substitutes
Loading...
Disclaimer
Did you find this information helpful?
Zuricab 0.5mg Tablet
Prescription Required
Salt Composition : Cabergoline
Manufacturer : ALKEM LABORATORIES LTD
Origin of Medicine : India
2 Tablet(s) In A Strip
Introduction to Zuricab 0.5mg Tablet
Zuricab 0.5mg Tablet is a medication containing Cabergoline, which is primarily used to treat conditions associated with excess production of prolactin, a hormone produced by the pituitary gland. Prolactinomas (benign tumors of the pituitary gland) are the most common cause of excessive prolactin levels, leading to symptoms like infertility, irregular menstrual cycles, and unwanted breast milk production (galactorrhea). Cabergoline helps reduce prolactin secretion by stimulating dopamine receptors in the brain, thereby correcting these hormone imbalances.
This medication is also used in treating Parkinson’s disease in some cases, as it aids in balancing the neurotransmitters in the brain, improving movement and reducing stiffness. Zuricab 0.5mg Tablet works by directly targeting the root cause of prolactin-related disorders, offering relief from the symptoms caused by elevated prolactin levels.
Uses of Zuricab 0.5mg Tablet
- Hyperprolactinemia: Treats elevated prolactin levels caused by prolactinomas or other conditions affecting the pituitary gland.
- Parkinson’s Disease: Sometimes used to treat Parkinson’s disease as a dopamine agonist to improve motor function.
Therapeutic Effects of Zuricab 0.5mg Tablet
Cabergoline in Zuricab 0.5mg Tablet effectively lowers prolactin levels in the blood by mimicking the effects of dopamine in the brain. This helps restore normal hormonal balance, alleviating symptoms such as galactorrhea, amenorrhea, and infertility. For patients with Parkinson’s disease, Zuricab can improve movement control and reduce stiffness by stimulating dopamine receptors in the brain. Regular use of the tablet significantly reduces the impact of prolactin-related conditions and helps prevent complications such as infertility and menstrual irregularities.
Interaction of Zuricab 0.5mg Tablet with other drugs
e cautious when combining Zuricab 0.5mg Tablet with other medications, as interactions may affect its effectiveness or increase the risk of side effects.
- Antipsychotic medications: Drugs like haloperidol and other dopamine antagonists can interfere with the action of Zuricab and reduce its effectiveness.
- Blood pressure medication: Cabergoline may lower blood pressure, so it may enhance the effects of antihypertensive medications.
- Ergot alkaloids: Combining Zuricab with ergot alkaloids (used for migraines) can increase the risk of vascular side effects.
More Information about Zuricab 0.5mg Tablet
- Storage: Store Zuricab 0.5mg Tablet in a cool, dry place away from direct light. Keep the tablets out of reach of children.
- Missed Dose: If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose. Do not take two doses at once.
- Overdose: If you suspect an overdose, contact your healthcare provider immediately. Symptoms may include severe dizziness, fainting, or difficulty breathing.
How to consume Zuricab 0.5mg Tablet
Take Zuricab 0.5mg Tablet orally with a glass of water, typically once or twice a week, depending on your doctor’s instructions. The tablet can be taken with or without food. Your doctor will adjust the dosage based on your response and prolactin levels, and it’s essential to follow the prescribed schedule to ensure optimal results. Do not break, chew, or crush the tablet.
Safety Advices for Zuricab 0.5mg Tablet
Pregnancy
Zuricab 0.5mg Tablet should be used during pregnancy only if clearly necessary. Consult your doctor if you are pregnant or planning to conceive.
Breast Feeding
Can suppress milk production, so it is not recommended for breastfeeding mothers.
Lungs
While lung-related issues are not common with Zuricab 0.5mg Tablet, some individuals may experience pleural effusion (fluid buildup in the lungs) and pulmonary fibrosis (lung tissue scarring) as rare side effects.
Liver
Liver-related side effects are rare but may include elevated liver enzymes. If you experience symptoms such as yellowing of the skin, dark urine, or persistent abdominal pain, consult your healthcare provider.
Alcohol
It is advisable to limit alcohol consumption while taking Zuricab 0.5mg Tablet as alcohol can increase the risk of dizziness and drowsiness.
Driving
Avoid driving or doing heavy mechanical work if you feel dizzy post taking the medicine.
Side Effects of Zuricab 0.5mg Tablet
Common side effects of Zuricab 0.5mg Tablet may include:
- Nausea
- Headache
- Dizziness
- Fatigue
- Abdominal pain
In rare cases, more severe side effects such as shortness of breath, chest pain, or leg swelling may occur. If you experience any of these symptoms, contact your doctor immediately.
Word of Advice
When using Zuricab 0.5mg Tablet, it's essential to follow your healthcare provider's instructions closely and attend regular check-ups to monitor your prolactin levels. Make sure to inform your doctor if you have a history of heart, liver, or kidney issues. Additionally, be aware of the potential side effects and seek medical attention immediately if you experience any unusual symptoms, especially if they involve difficulty breathing or chest pain.
FAQs
Q 1. How soon does Zuricab 0.5mg Tablet start working?
The medication generally starts to show effects within 1 to 2 weeks of initiating treatment, with prolactin levels gradually decreasing over time.
Q 2. How long do the effects of Zuricab 0.5mg Tablet last?
The effects of Zuricab 0.5mg Tablet can last for several days, depending on the individual’s response to the treatment. It is usually taken once or twice a week to maintain effective prolactin suppression.
Q 3. Can I drink alcohol while taking Zuricab 0.5mg Tablet?
It’s best to avoid alcohol while taking Zuricab 0.5mg Tablet, as alcohol may increase side effects like dizziness and drowsiness, making it harder to focus or maintain coordination.
Fact Box of Zuricab 0.5mg Tablet
Molecule name: Cabergoline | Therapeutic class: Dopamine Agonists |
Pharmacological class: Ergot Derivative
| Indications:
|
References
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
